Found: 43
Select item for more details and to access through your institution.
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 197, doi. 10.3350/cmh.2022.0404
- By:
- Publication type:
- Article
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 206, doi. 10.3350/cmh.2022.0402
- By:
- Publication type:
- Article
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Hong Kong perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 217, doi. 10.3350/cmh.2022.0399
- By:
- Publication type:
- Article
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 230, doi. 10.3350/cmh.2022.0421
- By:
- Publication type:
- Article
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 242, doi. 10.3350/cmh.2023.0102
- By:
- Publication type:
- Article
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 252, doi. 10.3350/cmh.2023.0099
- By:
- Publication type:
- Article
The role of different viral biomarkers on the man- agement of chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 263, doi. 10.3350/cmh.2022.0448
- By:
- Publication type:
- Article
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 277, doi. 10.3350/cmh.2022.0212
- By:
- Publication type:
- Article
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 293, doi. 10.3350/cmh.2022.0425
- By:
- Publication type:
- Article
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 320, doi. 10.3350/cmh.2022.0422
- By:
- Publication type:
- Article
What should be done to reduce the discrepancy between guidelines and real-life practice for hepa- tocellular carcinoma in Korea?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 332, doi. 10.3350/cmh.2023.0080
- By:
- Publication type:
- Article
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 335, doi. 10.3350/cmh.2023.0107
- By:
- Publication type:
- Article
The clinical management of hepatocellular carci- noma in China: Progress and challenges.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 339, doi. 10.3350/cmh.2023.0077
- By:
- Publication type:
- Article
Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 342, doi. 10.3350/cmh.2023.0106
- By:
- Publication type:
- Article
The prime time for management of hepatocellular carcinoma in Hong Kong.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 345, doi. 10.3350/cmh.2023.0094
- By:
- Publication type:
- Article
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 349, doi. 10.3350/cmh.2023.0082
- By:
- Publication type:
- Article
Challenges in translating clinical guidelines into real-life practice for management of hepatocellu- lar carcinoma in Taiwan.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 352, doi. 10.3350/cmh.2023.0101
- By:
- Publication type:
- Article
The latest global burden of liver cancer: A past and present threat.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 355, doi. 10.3350/cmh.2023.0070
- By:
- Publication type:
- Article
The current trends in the health burden of primary liver cancer across the globe.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 358, doi. 10.3350/cmh.2023.0092
- By:
- Publication type:
- Article
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 363, doi. 10.3350/cmh.2023.0079
- By:
- Publication type:
- Article
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 367, doi. 10.3350/cmh.2023.0054
- By:
- Publication type:
- Article
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associ- ated fatty liver disease is more than a change in terminology.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 371, doi. 10.3350/cmh.2023.0086
- By:
- Publication type:
- Article
The growing burden of non-alcoholic fatty liver disease on mortality.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 374, doi. 10.3350/cmh.2023.0084
- By:
- Publication type:
- Article
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 377, doi. 10.3350/cmh.2023.0061
- By:
- Publication type:
- Article
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 381, doi. 10.3350/cmh.2023.0088
- By:
- Publication type:
- Article
Implications of comorbidities in nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 384, doi. 10.3350/cmh.2023.0066
- By:
- Publication type:
- Article
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 390, doi. 10.3350/cmh.2023.0059
- By:
- Publication type:
- Article
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 394, doi. 10.3350/cmh.2023.0104
- By:
- Publication type:
- Article
Non-invasive biomarkers of liver fibrosis in nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 398, doi. 10.3350/cmh.2023.0045
- By:
- Publication type:
- Article
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and fu- ture.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 401, doi. 10.3350/cmh.2023.0062
- By:
- Publication type:
- Article
Hepatocellular carcinoma surveillance in non-alco- holic fatty liver disease – who and how?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 404, doi. 10.3350/cmh.2023.0069
- By:
- Publication type:
- Article
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 408, doi. 10.3350/cmh.2023.0085
- By:
- Publication type:
- Article
How to optimize the outcome of liver transplanta- tion for non-alcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 411, doi. 10.3350/cmh.2023.0058
- By:
- Publication type:
- Article
The independent effect of exercise on biopsy prov- en non-alcoholic fatty liver disease: A systematic review.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 414, doi. 10.3350/cmh.2023.0055
- By:
- Publication type:
- Article
Single-cell phenotypes of peripheral blood im- mune cells in early and late stages of non-alcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 417, doi. 10.3350/cmh.2022.0205
- By:
- Publication type:
- Article
Global burden of primary liver cancer and its asso- ciation with underlying aetiologies, sociodemo- graphic status, and sex differences from 1990– 2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 433, doi. 10.3350/cmh.2022.0316
- By:
- Publication type:
- Article
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 453, doi. 10.3350/cmh.2022.0450
- By:
- Publication type:
- Article
Taurocholic acid promotes hepatic stellate cell ac- tivation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 465, doi. 10.3350/cmh.2022.0327
- By:
- Publication type:
- Article
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 482, doi. 10.3350/cmh.2022.0322
- By:
- Publication type:
- Article
Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 496, doi. 10.3350/cmh.2022.0345
- By:
- Publication type:
- Article
Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 510, doi. 10.3350/cmh.2023.0018
- By:
- Publication type:
- Article
Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 513, doi. 10.3350/cmh.2023.0044
- By:
- Publication type:
- Article
Systemic therapy in advanced hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 516, doi. 10.3350/cmh.2023.0051
- By:
- Publication type:
- Article